OREM, Utah, Aug. 22, 2023 (GLOBE NEWSWIRE) — Reflect Scientific, Inc. (Symbol: RSCF), a leading provider of advanced cryogenic cooling solutions, is pleased to announce the receipt of a substantial order worth $200,000 from a major Bio-Pharma customer for its state-of-the-art Blast Freezers.
These high-performance Blast Freezers, known for their exceptional cooling efficiency and reliability, will be shipped during the third quarter of 2023. Reflect Scientific remains committed to delivering cutting-edge technology that meets the stringent requirements of the Bio-Pharma industry.
In addition to this significant order, Reflect Scientific is actively negotiating multiple contracts slated for shipment throughout 2023. Details of these upcoming contracts will be disclosed in due course as agreements are finalized.
Reflect Scientific’s CEO, Mr. Kim Boyce, expressed enthusiasm about the latest order and the Company’s continued expansion in providing innovative cryogenic solutions. The Company’s dedication to excellence and expertise in cryogenics reaffirms its position as a trusted partner in the Bio-Pharma sector.
About Reflect Scientific, Inc.
Reflect Scientific is a pioneering provider of advanced cryogenic cooling solutions that cater to diverse industrial needs. With a commitment to innovation and quality, Reflect Scientific stands as a reliable partner for industries requiring cutting-edge cooling technology. Among Reflect Scientific’s products are low-temperature freezers and refrigerated systems for laboratory, transportation, and computer server room uses. Visit reflectscientific.com for more information. See us on Twitter @ReflectSci and LinkedIn www.linkedin.com/company/reflect-scientific.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are not a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainties and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of the disclosures contained in the filings of the Company that are contained in the OTC Markets Group, LLC under the trading symbol “RSCF” and related prior filings by the Company that are referenced therein and contained in the EDGAR Archives of the Securities and Exchange Commission under the heading “Disclosure,” including those identified in such filings as “forward-looking statements.”
CONTACT: Contact Investor Relations 801-607-1039 investor_relations@reflectscientific.com
Ad hoc announcement pursuant to Art. 53 LR 2025 marks a key execution year in…
Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…
• Patient 1 of Cohort 1 has now completed the 24-month follow-up timepoint, and at…
LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…
Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…
Independent examination investigates SleepZee's moldable customization approach, medical-grade material claims, and manufacturer disclosure practices for…